Oramed Pharmaceuticals (ORMP) stock is rising on heavy volume trading on Monday after the clinical-stage pharmaceutical company announced a $50 million licensing deal in China.
These under-$10 stocks are within range of triggering breakout trades.
These under-$10 stocks are within range of triggering big breakout trades.
This beaten-down biotech stock could be ripe for a rebound.
Insiders at these companies have been scooping up shares of their own stock lately.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.